About Sinopsys Surgical
Sinopsys Surgical is a company based in Boulder (United States) founded in 2011. It operates as a B2B. Sinopsys Surgical has raised $9.57 million across 5 funding rounds from investors including Creathor Venture, Mercury Fund and High Country Ventures. Sinopsys Surgical operates in a competitive market with competitors including Oculeve, TearScience, Tear Film Innovations, Bruder Healthcare and Olympic Ophthalmics, among others.
- Headquarter Boulder, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$9.57 M (USD)
in 5 rounds
-
Latest Funding Round
Not available
-
Investors
Creathor Venture
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Sinopsys Surgical
Sinopsys Surgical has successfully raised a total of $9.57M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sinopsys Surgical
Sinopsys Surgical has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Creathor Venture, Mercury Fund and High Country Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Early-stage investments are directed toward US, India, and Canada firms.
|
Locked | Locked | Locked | |
|
Early-stage centric life sciences and tech focused VC firm investing primarily in the US
|
Locked | Locked | Locked |
Investor details for Sinopsys Surgical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sinopsys Surgical
Investment portfolio details for Sinopsys Surgical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sinopsys Surgical
Detailed financials for Sinopsys Surgical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sinopsys Surgical Comparisons
Peer comparison for Sinopsys Surgical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sinopsys Surgical
Sinopsys Surgical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oculeve, TearScience, Tear Film Innovations, Bruder Healthcare and Olympic Ophthalmics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A non-invasive nasal device for dry eye treatment is developed.
|
|
| Locked | Locked | Locked |
Devices for evaporative dry eye diagnosis and treatment are developed.
|
|
| Locked | Locked | Locked |
Evaporative dry eye is treated through meibomian gland stimulation devices.
|
|
| Locked | Locked | Locked |
Solutions for dry eye and pain management are developed.
|
|
| Locked | Locked | Locked |
Provider and developer of tear production device for treatments of dry eye disease
|
Detailed competitors of Sinopsys Surgical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sinopsys Surgical
Complete news archive for Sinopsys Surgical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sinopsys Surgical
Sinopsys Surgical was founded in 2011.
Sinopsys Surgical is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.
Sinopsys Surgical is a funded company, having raised a total of $9.57M across 5 funding rounds to date.
Sinopsys Surgical, based in Boulder, focuses on providing healthcare solutions, developing medical devices, surgical instruments, and sinusitis treatment. Offers lacrimal stents and procedures designed to effectively treat sinusitis. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Sinopsys Surgical's top competitors include Oculeve, Tear Film Innovations and TearScience.
Sinopsys Surgical has 3 investors. Key investors include Creathor Venture, Mercury Fund, and High Country Ventures.